Medical products company WAT Medical Enterprise Ltd announced on Monday the receipt of US FDA clearance for the EmeTerm wristband technology for the treatment of nausea-induced vomiting.

The company said EmeTerm is medication-free medical treatment, with no drug side effects of dizziness, drowsiness and increasing in the thickness of lung secretions. It effective for motion sickness and is safe and cleared by US FDA to be used for pregnancy-induced nausea and vomiting and morning sickness.

In conjunction, the EmeTerm's neuro modulation technology is US FDA cleared and clinical proven. The electric current is send to nerve system via P6 acupuncture point on underside of the wrist. The targeted electric pulses are delivered to brain and precisely block the signal of nausea and vomiting from brain to stomach. It are currently used by consumers in over 20 counties worldwide.

According to the company, EmeTerm is the winner of 2017 iF Design Award for its innovative design and usability. The patented electrodes design enhanced the transfer of electric pulses from device to skin. No conduct gel is needed which could bring more convenient and affordability to consumers.

Additionally, the company will attend the FIME 2018 Florida International Medical Expo from 17-19 July 2018. Both EmeTerm and HeadaTerm will be launched in the US. HeadaTerm, an anti-migraine device, is in the process of US FDA clearance and is expected to enter the US market along with EmeTerm.